A new study from the World health Organization finds the anti-viral
drug Remdesivir has little to no effect on Covid-19 patients' chances
of survival.
The drug's manufacturer has rejected the trial's findings.
US Correspondent Rachel Silverman has more.
IN: "The WHO trial…
OUT: SOC
DUR: 42 seconds
Generic: http://fsnradionews.com/feeds/1016remdes-rs-generic.mp3
The latest short-form news audio from FSN Bureaus worldwide